Trial Profile
To Evaluate Efficacy and Safety of Sofosbuvir in Combination with Daclatasvir or Simeprevir for 12 Weeks in Patients with Advanced Liver Disease Receiving
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2015
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Liver disorders
- Focus Therapeutic Use
- 14 Aug 2015 New trial record